Iranian Red Crescent Medical Journal

Published by: Kowsar

Association of Body Mass Index with Dyslipidemia among the Government Staff of Kermanshah, Iran: A Cross-Sectional Study

Ebrahim Shakiba 1 , Nahid Khademi 2 , Malihe Khoramdad 3 , * , Yousef Alimohamadi 4 , 5 and Neda Izadi 6
Authors Information
1 MD-PHD, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 MD, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 MSc of Epidemiology, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
4 Pars Advanced And Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran
5 Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran
6 PhD student of Epidemiology, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: August 2017, 19 (8); e58335
  • Published Online: July 25, 2017
  • Article Type: Research Article
  • Received: December 3, 2016
  • Revised: March 30, 2017
  • Accepted: May 7, 2017
  • DOI: 10.5812/ircmj.58335

To Cite: Shakiba E, Khademi N, Khoramdad M, Alimohamadi Y, Izadi N. Association of Body Mass Index with Dyslipidemia among the Government Staff of Kermanshah, Iran: A Cross-Sectional Study, Iran Red Crescent Med J. 2017 ; 19(8):e58335. doi: 10.5812/ircmj.58335.

Copyright © 2017, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Yusuf S, Wood D, Ralston J, Reddy KS. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet. 2015; 386(9991): 399-402[DOI][PubMed]
  • 2. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013; 40(1): 195-211[DOI][PubMed]
  • 3. Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, et al. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler. 2012; 18(9): 1310-9[DOI][PubMed]
  • 4. Chang CJ, Jian DY, Lin MW, Zhao JZ, Ho LT, Juan CC. Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity. PLoS One. 2015; 10(5)[DOI][PubMed]
  • 5. Canale MP, Manca di Villahermosa S, Martino G, Rovella V, Noce A, De Lorenzo A, et al. Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol. 2013; 2013: 865965[DOI][PubMed]
  • 6. Ogden CL, Carroll MD. Prevalence of overweight, obesity, and extreme obesity among adults: United States, trends 1960–1962 through 2007–2008. Nat Center Health Statistics. 2010; 6(1): 1-6
  • 7. Hirakawa Y, Lam TH, Welborn T, Kim HC, Ho S, Fang X, et al. The impact of body mass index on the associations of lipids with the risk of coronary heart disease in the Asia Pacific region. Prev Med Rep. 2016; 3: 79-82[DOI][PubMed]
  • 8. Rao W, Su Y, Yang G, Ma Y, Liu R, Zhang S, et al. Cross-Sectional Associations between Body Mass Index and Hyperlipidemia among Adults in Northeastern China. Int J Environ Res Public Health. 2016; 13(5)[DOI][PubMed]
  • 9. Khademi N, Babanejad M, Najafi F, Nikbakht MR, Hamzeh B, Mohammadi N. Tobacco Use and its Relationship with Health Complaints Among Employees of Kermanshah Province, Iran. Int J Prev Med. 2016; 7: 71[DOI][PubMed]
  • 10. Navaii L, Mehrabi Y, Azizi F. An epidemiologic study of hyperlipidemia, obesity, and hypertension in Tehran villages. Iran J Endocrinol Metab. 2000; 2(4): 253-62
  • 11. Garcia-Alvarez A, Serra-Majem L, Ribas-Barba L, Castell C, Foz M, Uauy R, et al. Obesity and overweight trends in Catalonia, Spain (1992-2003): gender and socio-economic determinants. Public Health Nutr. 2007; 10(11A): 1368-78[DOI][PubMed]
  • 12. Hedayati M. Central obesity as a reliable predictor for hypertension and dyslipidemia: Tehran Lipid Glucose Study. Iran J Endocrinol Metab. 2010; 12(3): 251-9
  • 13. Mohammadifard N, Sarafzadegan N, Nouri N, Bagheri M. The effect of passive smoking on acute myocardial infarction and it's relationship with fibrinogen and serum lipids. 2004;
  • 14. Biderafsh A, Karami M, Faradmal J, Poorolajal J, Esmailnasab N. The pattern of hypertension and the population attributable proportion of hypertension-related stroke in Hamadan province from 2005 to 2009. Iran J Epidemiol. 2014; 10(3): 54-64
  • 15. Yazdanpanah L, Shahbazian HB, Moravej Aleali A, Jahanshahi A, Ghanbari S, Latifi SM. Prevalence, awareness and risk factors of diabetes in Ahvaz (South West of Iran). Diabetes Metab Syndr. 2016; 10(2 Suppl 1)-8[DOI][PubMed]
  • 16. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004; 89(6): 2601-7[DOI][PubMed]
  • 17. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992; 85(1): 37-45[PubMed]
  • 18. Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients. World J Mens Health. 2015; 33(3): 167-73[DOI][PubMed]
  • 19. Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med. 2014; 5(4): 373-93[PubMed]
  • 20. Raj A, Sivakumar K, Sujatha K. Prevalence of dyslipidemia in South Indian adults: an urban-rural comparison. Int J Commun Med Public Health. 2017; 3(8): 2201-10
  • 21. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004; 291(23): 2847-50[DOI][PubMed]
  • 22. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008; 8: 200[DOI][PubMed]
  • 23. Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, et al. Obesity in South Africa: the South African demographic and health survey. Obes Res. 2002; 10(10): 1038-48[DOI][PubMed]
  • 24. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci. 2009; 64(2): 256-63[DOI][PubMed]
  • 25. Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, et al. [Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56(5-6): 661-7[DOI][PubMed]
  • 26. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008; 34(1-3): 36-51[DOI][PubMed]
  • 27. Lee MH, Kim HC, Ahn SV, Hur NW, Choi DP, Park CG, et al. Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J. 2012; 36(1): 43-55[DOI][PubMed]
  • 28. Gastaldelli A, Folli F, Maffei S. Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk. Curr Pharm Des. 2010; 16(23): 2526-30[PubMed]
  • 29. Haj Mouhamed D, Ezzaher A, Neffati F, Gaha L, Douki W, Najjar MF. Association between cigarette smoking and dyslipidemia. Immuno-analyse & Biologie Specialisee. 2013; 28(4): 195-200[DOI]
  • 30. Bruckert E, Jacob N, Lamaire L, Truffert J, Percheron F, de Gennes JL. Relationship between smoking status and serum lipids in a hyperlipidemic population and analysis of possible confounding factors. Clin Chem. 1992; 38(9): 1698-705[PubMed]
  • 31. Hirata K, Yamano Y, Suzuki H, Miyagawa S, Nakadate T. Passive smoking is associated with lower serum HDL-C levels in school children. Pediatr Int. 2010; 52(2): 252-6[DOI][PubMed]
  • 32. Neufeld EJ, Mietus-Snyder M, Beiser AS, Baker AL, Newburger JW. Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation. 1997; 96(5): 1403-7[PubMed]
  • 33. Lai SW, Ng KC, Lin HF, Chen HL. Association between obesity and hyperlipidemia among children. Yale J Biol Med. 2001; 74(4): 205-10[PubMed]
  • 34. Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical spending. Health Aff (Millwood). 2004; -480-6[DOI][PubMed]
  • 35. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008; 17(8): 1063-71[DOI][PubMed]
  • 36. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 1995; 36(4): 839-59[PubMed]
  • 37. Pradeepa R, Deepa R, Rani SS, Premalatha G, Saroja R, Mohan V. Socioeconomic status and dyslipidaemia in a South Indian population: the Chennai Urban Population Study (CUPS 11). Natl Med J India. 2003; 16(2): 73-8[PubMed]
  • 38. Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H. Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One. 2011; 6(3)[DOI][PubMed]
  • 39. F. Al-Kaabba A, A. Al-Hamdan N, El Tahir A, M. Abdalla A, A. Saeed A, A. Hamza M. Prevalence and Correlates of Dyslipidemia among Adults in Saudi Arabia: Results from a National Survey. Open J Endocrine Metab Dis. 2012; 2(4): 89-97[DOI]
  • 40. Luo Y, Li J, Zhang J, Xu Y. Low HDL cholesterol is correlated to the acute ischemic stroke with diabetes mellitus. Lipids Health Dis. 2014; 13: 171[DOI][PubMed]
  • 41. Lithell H. Hypertension and hyperlipidemia. A review. Am J Hypertens. 1993; 6(11 Pt 2): 303S-8S[PubMed]
  • 42. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, et al. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989; 9(3): 335-44[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments